{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:44:10Z","timestamp":1785797050832,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["Ratchadaphiseksomphot Endowment Fund"],"award-info":[{"award-number":["Ratchadaphiseksomphot Endowment Fund"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009570","name":"Srinakharinwirot University","doi-asserted-by":"publisher","award":["Faculty of Dentistry"],"award-info":[{"award-number":["Faculty of Dentistry"]}],"id":[{"id":"10.13039\/100009570","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Odontology"],"DOI":"10.1007\/s10266-026-01521-1","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:47:53Z","timestamp":1785793673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical factors associated with fluconazole resistance in oral Candida from xerostomic head and neck cancer patients"],"prefix":"10.1007","author":[{"given":"Aroonwan","family":"Lam-ubol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punnita","family":"Leerahakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supanat","family":"Tarapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panida","family":"Thanyasrisung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4029-6830","authenticated-orcid":false,"given":"Oranart","family":"Matangkasombut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"3","key":"1521_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"1521_CR2","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1002\/cam4.1221","volume":"6","author":"HY Sroussi","year":"2017","unstructured":"Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med. 2017;6(12):2918\u201331. https:\/\/doi.org\/10.1002\/cam4.1221.","journal-title":"Cancer Med"},{"issue":"2","key":"1521_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3857\/roj.2020.00213","volume":"38","author":"I Brook","year":"2020","unstructured":"Brook I. Late side effects of radiation treatment for head and neck cancer. Radiat Oncol J. 2020;38(2):84\u201392. https:\/\/doi.org\/10.3857\/roj.2020.00213.","journal-title":"Radiat Oncol J"},{"issue":"4","key":"1521_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.clindermatol.2016.02.022","volume":"34","author":"JW Millsop","year":"2016","unstructured":"Millsop JW, Fazel N. Oral candidiasis. Clin Dermatol. 2016;34(4):487\u201394. https:\/\/doi.org\/10.1016\/j.clindermatol.2016.02.022.","journal-title":"Clin Dermatol"},{"issue":"10","key":"1521_CR5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","volume":"25","author":"P Koehler","year":"2019","unstructured":"Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild M, Bohlius J, et al. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect. 2019;25(10):1200\u201312. https:\/\/doi.org\/10.1016\/j.cmi.2019.04.024.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"1521_CR6","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1007\/s00784-022-04716-2","volume":"26","author":"SQS Kessler","year":"2022","unstructured":"Kessler SQS, Lang PM, Dal-Pizzol TS, Montagner F. Resistance profiles to antifungal agents in Candida albicans isolated from human oral cavities: systematic review and meta-analysis. Clin Oral Investig. 2022;26(11):6479\u201389. https:\/\/doi.org\/10.1007\/s00784-022-04716-2.","journal-title":"Clin Oral Investig"},{"issue":"7","key":"1521_CR7","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/odi.13151","volume":"25","author":"S Tarapan","year":"2019","unstructured":"Tarapan S, Matangkasombut O, Trachootham D, Sattabanasuk V, Talungchit S, Paemuang W, et al. Oral Candida colonization in xerostomic postradiotherapy head and neck cancer patients. Oral Dis. 2019;25(7):1798\u2013808. https:\/\/doi.org\/10.1111\/odi.13151.","journal-title":"Oral Dis"},{"key":"1521_CR8","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2147\/IDR.S316368","volume":"14","author":"J Wu","year":"2021","unstructured":"Wu J, Gan C, Li J, Liu Y, Chen Z, Zhang Y, et al. Species diversity and antifungal susceptibilities of oral yeasts from patients with head and neck cancer. Infect Drug Resist. 2021;14:2279\u201388. https:\/\/doi.org\/10.2147\/IDR.S316368.","journal-title":"Infect Drug Resist"},{"issue":"9","key":"1521_CR9","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1111\/odi.15060","volume":"31","author":"J Bhumitrakul","year":"2025","unstructured":"Bhumitrakul J, Lam-Ubol A, Matangkasombut O. Oral Candida in post-radiotherapy patients with xerostomia\/hyposalivation: a narrative review. Oral Dis. 2025;31(9):2723\u201338. https:\/\/doi.org\/10.1111\/odi.15060.","journal-title":"Oral Dis"},{"issue":"4","key":"1521_CR10","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1128\/JCM.02117-09","volume":"48","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48(4):1366\u201377. https:\/\/doi.org\/10.1128\/JCM.02117-09.","journal-title":"J Clin Microbiol"},{"key":"1521_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/IDR.S118892","volume":"10","author":"EL Berkow","year":"2017","unstructured":"Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 2017;10:237\u201345. https:\/\/doi.org\/10.2147\/IDR.S118892.","journal-title":"Infect Drug Resist"},{"issue":"6","key":"1521_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","volume":"18","author":"J Berman","year":"2020","unstructured":"Berman J, Krysan DJ. Drug resistance and tolerance in fungi. Nat Rev Microbiol. 2020;18(6):319\u201331. https:\/\/doi.org\/10.1038\/s41579-019-0322-2.","journal-title":"Nat Rev Microbiol"},{"key":"1521_CR13","doi-asserted-by":"publisher","first-page":"105495","DOI":"10.1016\/j.archoralbio.2022.105495","volume":"142","author":"P Leerahakan","year":"2022","unstructured":"Leerahakan P, Matangkasombut O, Tarapan S, Lam-Ubol A. Biofilm formation of Candida isolates from xerostomic post-radiotherapy head and neck cancer patients. Arch Oral Biol. 2022;142:105495. https:\/\/doi.org\/10.1016\/j.archoralbio.2022.105495.","journal-title":"Arch Oral Biol"},{"issue":"Pt 5","key":"1521_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1099\/jmm.0.069773-0","volume":"63","author":"P Thanyasrisung","year":"2014","unstructured":"Thanyasrisung P, Kesakomol P, Pipattanagovit P, Youngnak-Piboonratanakit P, Pitiphat W, Matangkasombut O. Oral Candida carriage and immune status in Thai human immunodeficiency virus-infected individuals. J Med Microbiol. 2014;63(Pt 5):753\u20139. https:\/\/doi.org\/10.1099\/jmm.0.069773-0.","journal-title":"J Med Microbiol"},{"key":"1521_CR15","doi-asserted-by":"publisher","first-page":"105628","DOI":"10.1016\/j.archoralbio.2023.105628","volume":"147","author":"P Thanyasrisung","year":"2023","unstructured":"Thanyasrisung P, Satitviboon W, Howattanapanich S, Matangkasombut O. Antifungal drug resistance in oral Candida isolates from HIV-infected and healthy individuals and efficacy of chitosan as an alternative antifungal agent. Arch Oral Biol. 2023;147:105628. https:\/\/doi.org\/10.1016\/j.archoralbio.2023.105628.","journal-title":"Arch Oral Biol"},{"issue":"5","key":"1521_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.oooo.2012.05.009","volume":"114","author":"SM Osailan","year":"2012","unstructured":"Osailan SM, Pramanik R, Shirlaw P, Proctor GB, Challacombe SJ. Clinical assessment of oral dryness: development of a scoring system related to salivary flow and mucosal wetness. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(5):597\u2013603. https:\/\/doi.org\/10.1016\/j.oooo.2012.05.009.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1521_CR17","volume-title":"Performance Standards for Antifungal Susceptibility Testing of Yeasts. CLSI supplement M60","author":"CLSI","year":"2020","unstructured":"CLSI. Performance standards for antifungal susceptibility testing of yeasts. CLSI supplement M60. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.","edition":"2"},{"issue":"18","key":"1521_CR18","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","volume":"183","author":"J Chandra","year":"2001","unstructured":"Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183(18):5385\u201394. https:\/\/doi.org\/10.1128\/JB.183.18.5385-5394.2001.","journal-title":"J Bacteriol"},{"key":"1521_CR19","doi-asserted-by":"publisher","first-page":"102237","DOI":"10.1016\/j.mib.2022.102237","volume":"71","author":"J Kaur","year":"2023","unstructured":"Kaur J, Nobile CJ. Antifungal drug-resistance mechanisms in Candida biofilms. Curr Opin Microbiol. 2023;71:102237. https:\/\/doi.org\/10.1016\/j.mib.2022.102237.","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"1521_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.prosdent.2019.12.025","volume":"125","author":"J Fang","year":"2021","unstructured":"Fang J, Huang B, Ding Z. Efficacy of antifungal drugs in the treatment of oral candidiasis: a Bayesian network meta-analysis. J Prosthet Dent. 2021;125(2):257\u201365. https:\/\/doi.org\/10.1016\/j.prosdent.2019.12.025.","journal-title":"J Prosthet Dent"},{"issue":"1","key":"1521_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.18502\/ijm.v15i1.11933","volume":"15","author":"Z Jahanshiri","year":"2023","unstructured":"Jahanshiri Z, Manifar S, Hatami F. Evaluation of virulence factors and azole resistance mechanisms of Candida tropicalis isolates from head and neck cancer patients with OPC. Iran J Microbiol. 2023;15(1):163\u201373. https:\/\/doi.org\/10.18502\/ijm.v15i1.11933.","journal-title":"Iran J Microbiol"},{"issue":"6","key":"1521_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1399-302x.2004.00165.x","volume":"19","author":"M Belazi","year":"2004","unstructured":"Belazi M, Velegraki A, Koussidou-Eremondi T, Andreadis D, Hini S, Arsenis G, et al. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microbiol Immunol. 2004;19(6):347\u201351. https:\/\/doi.org\/10.1111\/j.1399-302x.2004.00165.x.","journal-title":"Oral Microbiol Immunol"},{"key":"1521_CR23","doi-asserted-by":"publisher","first-page":"8758461","DOI":"10.1155\/2016\/8758461","volume":"2016","author":"AL Jayachandran","year":"2016","unstructured":"Jayachandran AL, Katragadda R, Thyagarajan R, Vajravelu L, Manikesi S, Kaliappan S, et al. Oral Candidiasis among cancer patients attending a tertiary care hospital in Chennai, South India: an evaluation of clinicomycological association and antifungal susceptibility pattern. Can J Infect Dis Med Microbiol. 2016;2016:8758461. https:\/\/doi.org\/10.1155\/2016\/8758461.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"7","key":"1521_CR24","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1128\/AAC.45.7.2129-2133.2001","volume":"45","author":"A Safdar","year":"2001","unstructured":"Safdar A, Chaturvedi V, Cross EW, Park S, Bernard EM, Armstrong D, et al. Prospective study of Candida species in patients at a comprehensive cancer center. Antimicrob Agents Chemother. 2001;45(7):2129\u201333. https:\/\/doi.org\/10.1128\/AAC.45.7.2129-2133.2001.","journal-title":"Antimicrob Agents Chemother"},{"key":"1521_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4103\/abr.abr_214_19","volume":"9","author":"M Maheronnaghsh","year":"2020","unstructured":"Maheronnaghsh M, Fatahinia M, Dehghan P, Teimoori A. Identification of Candida species and antifungal susceptibility in cancer patients with oral lesions in Ahvaz, Southern West of Iran. Adv Biomed Res. 2020;9:50. https:\/\/doi.org\/10.4103\/abr.abr_214_19.","journal-title":"Adv Biomed Res"},{"issue":"3\u20134","key":"1521_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1439-0507.1995.tb00032.x","volume":"38","author":"P Marichal","year":"1995","unstructured":"Marichal P, Gorrens J, Coene MC, Le Jeune L, Vanden Bossche H. Origin of differences in susceptibility of Candida krusei to azole antifungal agents. Mycoses. 1995;38(3\u20134):111\u20137. https:\/\/doi.org\/10.1111\/j.1439-0507.1995.tb00032.x.","journal-title":"Mycoses"},{"issue":"2","key":"1521_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1128\/JCM.01915-07","volume":"46","author":"MA Pfaller","year":"2008","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Nagy E, Dobiasova S, et al. Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program, 2001 to 2005. J Clin Microbiol. 2008;46(2):515\u201321. https:\/\/doi.org\/10.1128\/JCM.01915-07.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1521_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.mycmed.2018.01.001","volume":"28","author":"Z Jahanshiri","year":"2018","unstructured":"Jahanshiri Z, Manifar S, Moosa H, Asghari-Paskiabi F, Mahmoodzadeh H, Shams-Ghahfarokhi M, et al. Oropharyngeal candidiasis in head and neck cancer patients in Iran: species identification, antifungal susceptibility and pathogenic characterization. J Mycol Med. 2018;28(2):361\u20136. https:\/\/doi.org\/10.1016\/j.mycmed.2018.01.001.","journal-title":"J Mycol Med"},{"key":"1521_CR29","doi-asserted-by":"publisher","first-page":"100659","DOI":"10.1016\/j.onehlt.2023.100659","volume":"18","author":"BVG Nguyen","year":"2024","unstructured":"Nguyen BVG, Nguyen HHN, Vo TH, Le MT, Tran-Nguyen VK, Vu TT, et al. Prevalence and drug susceptibility of clinical Candida species in nasopharyngeal cancer patients in Vietnam. One Health. 2024;18:100659. https:\/\/doi.org\/10.1016\/j.onehlt.2023.100659.","journal-title":"One Health"},{"issue":"4","key":"1521_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/1040841X.2010.489506","volume":"36","author":"LY Chai","year":"2010","unstructured":"Chai LY, Denning DW, Warn P. Candida tropicalis in human disease. Crit Rev Microbiol. 2010;36(4):282\u201398. https:\/\/doi.org\/10.3109\/1040841X.2010.489506.","journal-title":"Crit Rev Microbiol"},{"key":"1521_CR31","doi-asserted-by":"publisher","unstructured":"Beardsley J, Kim HY, Dao A, Kidd S, Alastruey-Izquierdo A, Sorrell TC, et al. Candida glabrata (Nakaseomyces glabrata): a systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization fungal priority pathogens list. Med Mycol. 2024. https:\/\/doi.org\/10.1093\/mmy\/myae041.","DOI":"10.1093\/mmy\/myae041"},{"issue":"3","key":"1521_CR32","doi-asserted-by":"publisher","first-page":"e1005522","DOI":"10.1371\/journal.ppat.1005522","volume":"12","author":"S Tati","year":"2016","unstructured":"Tati S, Davidow P, McCall A, Hwang-Wong E, Rojas IG, Cormack B, et al. Candida glabrata binding to Candida albicans hyphae enables its development in oropharyngeal candidiasis. PLoS Pathog. 2016;12(3):e1005522. https:\/\/doi.org\/10.1371\/journal.ppat.1005522.","journal-title":"PLoS Pathog"},{"issue":"Suppl 1","key":"1521_CR33","first-page":"S147","volume":"107","author":"N Manomaiwong","year":"2024","unstructured":"Manomaiwong N, Kuwatjanakul W, Meesing A, Samerpitak K, Wonglakorn L, Sribenjalux W. Case series of Kodamaea ohmeri: an emerging fungal infection in Srinagarind Hospital, Thailand. J Med Assoc Thai. 2024;107(Suppl 1):S147\u201351.","journal-title":"J Med Assoc Thai"},{"key":"1521_CR34","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.2147\/IDR.S211033","volume":"12","author":"M Zhou","year":"2019","unstructured":"Zhou M, Yu S, Kudinha T, Xiao M, Wang H, Xu Y, et al. Identification and antifungal susceptibility profiles of Kodamaea ohmeri based on a seven-year multicenter surveillance study. Infect Drug Resist. 2019;12:1657\u201364. https:\/\/doi.org\/10.2147\/IDR.S211033.","journal-title":"Infect Drug Resist"},{"issue":"9","key":"1521_CR35","doi-asserted-by":"publisher","first-page":"e1003550","DOI":"10.1371\/journal.ppat.1003550","volume":"9","author":"N Papon","year":"2013","unstructured":"Papon N, Courdavault V, Clastre M, Bennett RJ. Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm. PLoS Pathog. 2013;9(9):e1003550. https:\/\/doi.org\/10.1371\/journal.ppat.1003550.","journal-title":"PLoS Pathog"},{"key":"1521_CR36","doi-asserted-by":"publisher","unstructured":"Berkow EL, Lockhart SR, Ostrosky-Zeichner L. Antifungal susceptibility testing: current approaches. Clin Microbiol Rev. 2020. https:\/\/doi.org\/10.1128\/CMR.00069-19.","DOI":"10.1128\/CMR.00069-19"},{"issue":"4","key":"1521_CR37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/jac\/dkl555","volume":"59","author":"R Fleck","year":"2007","unstructured":"Fleck R, Dietz A, Hof H. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother. 2007;59(4):767\u201371. https:\/\/doi.org\/10.1093\/jac\/dkl555.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1521_CR38","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1128\/JCM.01840-06","volume":"45","author":"BD Alexander","year":"2007","unstructured":"Alexander BD, Byrne TC, Smith KL, Hanson KE, Anstrom KJ, Perfect JR, et al. Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol. 2007;45(3):698\u2013706. https:\/\/doi.org\/10.1128\/JCM.01840-06.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1521_CR39","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1128\/jcm.01398-10","volume":"49","author":"MA Pfaller","year":"2011","unstructured":"Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J Clin Microbiol. 2011;49(1):396\u20139. https:\/\/doi.org\/10.1128\/jcm.01398-10.","journal-title":"J Clin Microbiol"},{"key":"1521_CR40","doi-asserted-by":"publisher","unstructured":"Li X, Sholeh M, Moghadam MA, Ostadrahimi M, Hosseini SS. Global prevalence and trends of fluconazole resistance in non-albicans Candida species: a systematic review and meta-analysis. BMC Infect Dis. 2026. https:\/\/doi.org\/10.1186\/s12879-026-12653-8.","DOI":"10.1186\/s12879-026-12653-8"},{"issue":"6","key":"1521_CR41","doi-asserted-by":"publisher","first-page":"e0161725","DOI":"10.1128\/aac.01617-25","volume":"70","author":"G Cai","year":"2026","unstructured":"Cai G, Zhang Z. Global surveillance of Candida albicans: MIC distributions, resistance patterns, and temporal trends from the antimicrobial testing leadership and surveillance program (2015\u20132024). Antimicrob Agents Chemother. 2026;70(6):e0161725. https:\/\/doi.org\/10.1128\/aac.01617-25.","journal-title":"Antimicrob Agents Chemother"},{"key":"1521_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fmicb.2015.00205","volume":"6","author":"A Silva-Dias","year":"2015","unstructured":"Silva-Dias A, Miranda IM, Branco J, Monteiro-Soares M, Pina-Vaz C, Rodrigues AG. Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp. Front Microbiol. 2015;6:205. https:\/\/doi.org\/10.3389\/fmicb.2015.00205.","journal-title":"Front Microbiol"},{"issue":"3","key":"1521_CR43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1590\/s0074-02762005000300019","volume":"100","author":"S Ozkan","year":"2005","unstructured":"Ozkan S, Kaynak F, Kalkanci A, Abbasoglu U, Kustimur S. Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents. Mem Inst Oswaldo Cruz. 2005;100(3):319\u201323. https:\/\/doi.org\/10.1590\/s0074-02762005000300019.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1521_CR44","doi-asserted-by":"publisher","unstructured":"Marzucco A, Gatti G, Montanari MS, Fantini M, Colosimo C, Tamburini MV, et al. Evaluation of Biofilm production and antifungal susceptibility to fluconazole in clinical isolates of Candida spp. in both planktonic and biofilm form. Microorganisms. 2024. https:\/\/doi.org\/10.3390\/microorganisms12010153.","DOI":"10.3390\/microorganisms12010153"},{"issue":"5","key":"1521_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2323\/jgam.60.163","volume":"60","author":"SK Doke","year":"2014","unstructured":"Doke SK, Raut JS, Dhawale S, Karuppayil SM. Sensitization of Candida albicans biofilms to fluconazole by terpenoids of plant origin. J Gen Appl Microbiol. 2014;60(5):163\u20138. https:\/\/doi.org\/10.2323\/jgam.60.163.","journal-title":"J Gen Appl Microbiol"},{"issue":"3","key":"1521_CR46","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1567-1364.2007.00347.x","volume":"8","author":"FC Bizerra","year":"2008","unstructured":"Bizerra FC, Nakamura CV, de Poersch C, Estivalet Svidzinski TI, Borsato Quesada RM, Goldenberg S, et al. Characteristics of biofilm formation by Candida tropicalis and antifungal resistance. FEMS Yeast Res. 2008;8(3):442\u201350. https:\/\/doi.org\/10.1111\/j.1567-1364.2007.00347.x.","journal-title":"FEMS Yeast Res"},{"key":"1521_CR47","doi-asserted-by":"publisher","unstructured":"Silva S, Rodrigues CF, Araujo D, Rodrigues ME, Henriques M. Candida species biofilms\u2019 antifungal resistance. J Fungi (Basel). 2017. https:\/\/doi.org\/10.3390\/jof3010008.","DOI":"10.3390\/jof3010008"},{"key":"1521_CR48","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.2147\/IDR.S420580","volume":"16","author":"MA Gerges","year":"2023","unstructured":"Gerges MA, Fahmy YA, Hosny T, Gandor NH, Mohammed SY, Mohamed TMA, et al. Biofilm formation and aspartyl proteinase activity and their association with azole resistance among Candida albicans causing vulvovaginal candidiasis, Egypt. Infect Drug Resist. 2023;16:5283\u201393. https:\/\/doi.org\/10.2147\/IDR.S420580.","journal-title":"Infect Drug Resist"},{"issue":"8","key":"1521_CR49","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1128\/AAC.00479-10","volume":"54","author":"J Garnacho-Montero","year":"2010","unstructured":"Garnacho-Montero J, Diaz-Martin A, Garcia-Cabrera E, Ruiz Perez de Pipaon M, Hernandez-Caballero C, Aznar-Martin J, et al. Risk factors for fluconazole-resistant candidemia. Antimicrob Agents Chemother. 2010;54(8):3149\u201354. https:\/\/doi.org\/10.1128\/AAC.00479-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1521_CR50","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","volume":"25","author":"OA Cornely","year":"2025","unstructured":"Cornely OA, Sprute R, Bassetti M, Chen SC, Groll AH, Kurzai O, et al. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2025;25(5):e280\u201393. https:\/\/doi.org\/10.1016\/S1473-3099(24)00749-7.","journal-title":"Lancet Infect Dis"},{"key":"1521_CR51","doi-asserted-by":"publisher","unstructured":"Chakrabarti A, Oladele R, Hermsen E, Novis de Figueiredo ML, Munoz P, Johnson M. Building upon the core elements of antifungal stewardship: practical recommendations for effective antifungal stewardship in resource-limited settings. Expert Rev Anti Infect Ther. 2025. https:\/\/doi.org\/10.1080\/14787210.2025.2479011.","DOI":"10.1080\/14787210.2025.2479011"},{"issue":"1","key":"1521_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s44259-023-00007-2","volume":"1","author":"Y Lee","year":"2023","unstructured":"Lee Y, Robbins N, Cowen LE. Molecular mechanisms governing antifungal drug resistance. npj antimicrobials Resist. 2023;1(1):5. https:\/\/doi.org\/10.1038\/s44259-023-00007-2.","journal-title":"npj antimicrobials Resist"},{"issue":"6","key":"1521_CR53","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","volume":"121","author":"Y Lee","year":"2021","unstructured":"Lee Y, Puumala E, Robbins N, Cowen LE. Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond. Chem Rev. 2021;121(6):3390\u2013411. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00199.","journal-title":"Chem Rev"},{"issue":"Suppl 1","key":"1521_CR54","doi-asserted-by":"publisher","first-page":"S702","DOI":"10.4103\/jpbs.jpbs_781_21","volume":"14","author":"S Manikandan","year":"2022","unstructured":"Manikandan S, Vinesh E, Selvi DT, Kannan RK, Jayakumar A, Dinakaran J. Prevalence of Candida among denture wearers and nondenture wearers. J Pharm Bioallied Sci. 2022;14(Suppl 1):S702\u20135. https:\/\/doi.org\/10.4103\/jpbs.jpbs_781_21.","journal-title":"J Pharm Bioallied Sci"}],"container-title":["Odontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-026-01521-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10266-026-01521-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-026-01521-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:47:55Z","timestamp":1785793675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10266-026-01521-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":54,"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1007\/s10266-026-01521-1","relation":{},"ISSN":["1618-1247","1618-1255"],"issn-type":[{"value":"1618-1247","type":"print"},{"value":"1618-1255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by human research ethic committees of Srinakharinwirot university (Approval number SWUEC-032\/2563X) and of Faculty of Dentistry, Chulalongkorn university (Approval number 041\/2021), and was conducted in accordance with the World Medical Association Declaration of Helsinki. All participants provided written informed consent before enrollment in the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}